Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 6, Number 9, September 2008

Free Content Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? Yes
pp. 1445-1449(5)
Authors: THACKER, S. M.; GRICE, G. R.; MILLIGAN, P. E.; GAGE, B. F.

Favourites:
ADD

Free Content Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? No
pp. 1450-1452(3)
Authors: MANNUCCI, P. M.; SPREAFICO, M.; PEYVANDI, F.

Favourites:
ADD

Free Content Endothelial cell junctions and the regulation of vascular permeability and leukocyte transmigration
pp. 1453-1460(8)
Authors: AGHAJANIAN, A.; WITTCHEN, E. S.; ALLINGHAM, M. J.; GARRETT, T. A.; BURRIDGE, K.

Favourites:
ADD

Free Content Where do we go now with low molecular weight heparin use in obstetric care?
pp. 1461-1467(7)
Authors: PATEL, J. P.; HUNT, B. J.

Favourites:
ADD

Free Content Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation
pp. 1468-1473(6)
Authors: GONSALVES, A.; CARRIER, M.; WELLS, P. S.; MCDIARMID, S. A.; HUEBSCH, L. B.; ALLAN, D. S.

Favourites:
ADD

Free Content Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis
pp. 1474-1477(4)
Authors: COPPENS, M.; REIJNDERS, J. H.; MIDDELDORP, S.; DOGGEN, C. J. M.; ROSENDAAL, F. R.

Favourites:
ADD

Free Content Contribution of indirect computed tomographic venography to the diagnosis of postpartum venous thromboembolism
pp. 1478-1481(4)
Authors: REVEL, M. P.; SANCHEZ, O.; DECHOUX, S.; COUCHON, S.; FRIJA, G.; CAZEJUST, J.; CHATELLIER, G.; MEYER, G.

Favourites:
ADD

Free Content Increased acquired activated protein C resistance in unselected patients with hematological malignancies
pp. 1482-1487(6)
Authors: NEGAARD, H. F. S.; IVERSEN, P. O.; ØSTENSTAD, B.; MOWINCKEL, M. C.; SANDSET, P. M.

Favourites:
ADD

Free Content Real-time risk stratification of patients with acute pulmonary embolism by grading the reflux of contrast into the inferior vena cava on computerized tomographic pulmonary angiography
pp. 1488-1493(6)
Authors: AVIRAM, G.; ROGOWSKI, O.; GOTLER, Y.; BENDLER, A.; STEINVIL, A.; GOLDIN, Y.; GRAIF, M.; BERLINER, S.

Favourites:
ADD

Free Content Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate
pp. 1494-1499(6)
Authors: NÉGRIER, C.; ROTHSCHILD, C.; GOUDEMAND, J.; BORG, J. Y.; CLAEYSSENS, S.; ALESSI, M. C.; JAFFRY, A. C.; TEBOUL, C.; PADRAZZI, B.; WAEGEMANS, T.

Favourites:
ADD

Free Content The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction
pp. 1507-1513(7)
Authors: SPENCER, F. A.; GINSBERG, J. S.; CHONG, A.; ALTER, D. A.

Favourites:
ADD
Favourites:
ADD

Free Content Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation
pp. 1517-1524(8)
Authors: DAVILA, M.; AMIRKHOSRAVI, A.; COLL, E.; DESAI, H.; ROBLES, L.; COLON, J.; BAKER, C. H.; FRANCIS, J. L.

Favourites:
ADD

Free Content Activity and regulation of glycoPEGylated factor VIIa analogs
pp. 1525-1533(9)
Authors: GHOSH, S.; SEN, P.; PENDURTHI, U. R.; RAO, L. V. M.

Favourites:
ADD

Free Content Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13)
pp. 1534-1541(8)
Authors: TRIPODI, A.; PEYVANDI, F.; CHANTARANGKUL, V.; PALLA, R.; AFRASIABI, A.; CANCIANI, M. T.; CHUNG, D. W.; FERRARI, S.; FUJIMURA, Y.; KARIMI, M.; KOKAME, K.; KREMER HOVINGA, J. A.; LÄMMLE, B.; DE MEYER, S. F.; PLAIMAUER, B.; VANHOORELBEKE, K.; VARADI, K.; MANNUCCI, P. M.

Favourites:
ADD

Free Content DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles
pp. 1542-1549(8)
Authors: FURUGOHRI, T.; ISOBE, K.; HONDA, Y.; KAMISATO-MATSUMOTO, C.; SUGIYAMA, N.; NAGAHARA, T.; MORISHIMA, Y.; SHIBANO, T.

Favourites:
ADD

Free Content TF:FVIIa-specific activation of CREB upregulates proapoptotic proteins via protease-activated receptor-2
pp. 1550-1557(8)
Authors: VERSTEEG, H. H.; BORENSZTAJN, K. S.; KERVER, M. E.; RUF, W.; REITSMA, P. H.; SPEK, C. A.; PEPPELENBOSCH, M. P.

Favourites:
ADD

Free Content Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis
pp. 1558-1564(7)
Authors: HENNAN, J. K.; MORGAN, G. A.; SWILLO, R. E.; ANTRILLI, T. M.; MUGFORD, C.; VLASUK, G. P.; GARDELL, S. J.; CRANDALL, D. L.

Favourites:
ADD

Free Content Evidence that α2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation
pp. 1565-1570(6)
Authors: MOSESSON, M. W.; SIEBENLIST, K. R.; HERNANDEZ, I.; LEE, K. N.; CHRISTIANSEN, V. J.; MCKEE, P. A.

Favourites:
ADD

Free Content Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential
pp. 1571-1577(7)
Authors: COLUCCI, M.; CATTANEO, M.; MARTINELLI, I.; SEMERARO, F.; BINETTI, B. M.; SEMERARO, N.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Free Content An algorithm for resolving ‘indeterminate’ test results in the platelet serotonin release assay for investigation of heparin-induced thrombocytopenia
pp. 1595-1597(3)
Authors: MOORE, J. C.; ARNOLD, D. M.; WARKENTIN, T. E.; WARKENTIN, A. E.; KELTON, J. G.

Favourites:
ADD
Favourites:
ADD

Free Content Absence of the JAK2 V617F mutation in patients with arterial thrombosis without overt myeloproliferative disease
pp. 1606-1607(2)
Authors: SMALBERG, J. H.; DE MAAT, M. P. M.; LEEBEEK, F. W. G.

Favourites:
ADD

Free Content Exclusion of ABCA-1 as a candidate gene for canine Scott syndrome
pp. 1608-1610(3)
Authors: BROOKS, M. B.; CATALFAMO, J. L.; ETTER, K.; BRISBIN, A.; BUSTAMANTE, C. D.

Favourites:
ADD

Free Content Sequence variants and haplotypes of the factor IX gene and the risk of venous thrombosis
pp. 1610-1613(4)
Authors: VAN MINKELEN, R.; DE VISSER, M. C. H.; VAN HYLCKAMA VLIEG, A.; VOS, H. L.; BERTINA, R. M.

Favourites:
ADD

Free Content Join ISTH
pp. 1614-1614(1)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more